(Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3,405.59%54.44K | 97.81%-13.05K | -33.52%-95.68K | 77.51%-579.16K | 116.93%89.77K | 99.79%-1.65K | -10.45%-595.62K | 90.28%-71.66K | -20.31%-2.58M | -16.45%-530.13K |
Net income from continuing operations | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K | -7.16%-652.76K | -81.62%-4.07M | -105.38%-1.13M |
Operating gains losses | ---- | ---- | ---- | 22.14%-20.44K | -0.55%-22.59K | ---- | ---- | -34.56%2.14K | -275.65%-26.26K | -153.12%-22.46K |
Depreciation and amortization | -95.07%7.54K | -95.06%7.57K | -82.92%26.71K | 62.57%615.16K | -6.06%152.7K | -6.02%152.96K | 294.02%153.12K | 1,000.05%156.37K | 328.17%378.39K | 1,062.89%162.56K |
Asset impairment expenditure | ---- | ---- | ---- | --870.41K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | -83.54%4.21K | -72.76%17.8K | -102.06%-3.21K | -59.94%246.2K | -100.06%-102 | -90.43%25.55K | -62.58%65.34K | 12,323.90%155.42K | 1,595.79%614.57K | 5,359.91%171.74K |
Other non cashItems | 6.63%31.2K | 80.02%30.61K | 117.58%29.02K | -170.44%-89.96K | -18.13%28.83K | -10.20%29.26K | -44.79%17K | -666.69%-165.05K | 21.07%127.72K | 30.86%35.22K |
Change In working capital | -93.72%21.27K | 179.13%131.97K | -73.91%112.75K | 119.92%873.28K | 5.25%269.02K | 420.84%338.83K | -166.09%-166.78K | 345.68%432.21K | 371.17%397.09K | 278.32%255.6K |
-Change in receivables | 2.16%87.87K | 15.84%-84.52K | 130.58%81.1K | -121.43%-39.38K | -147.24%-60.14K | 747.34%86.02K | -82,219.67%-100.43K | -49.61%35.17K | --183.71K | --127.31K |
-Change in inventory | -270.21%-7.56K | -122.30%-25.11K | 95.04%-5.22K | 392.99%20.23K | -76.45%8.53K | 111.87%4.44K | 8,000.07%112.59K | -1,385.03%-105.33K | ---6.9K | --36.22K |
-Change in prepaid assets | -4,159.31%-139.76K | -832.30%-182.04K | -95.36%2.19K | 292.28%74.52K | -101.08%-1.08K | -94.98%3.44K | -74.08%24.86K | 115.61%47.3K | ---38.76K | --99.77K |
-Change in payables and accrued expense | -56.01%123.22K | -118.17%-6.32K | -100.65%-1.85K | 348.79%921.79K | 1,148.92%324.08K | 973.37%280.12K | -53.01%34.78K | 105.67%282.81K | --205.4K | --25.95K |
-Change in other working capital | -20.75%-42.5K | 280.21%429.96K | -78.80%36.52K | -293.63%-103.88K | 92.94%-2.38K | -144.41%-35.2K | -393.86%-238.58K | 335.57%172.27K | --53.65K | ---33.65K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3,405.59%54.44K | 97.81%-13.05K | -33.52%-95.68K | 77.51%-579.16K | 116.93%89.77K | 99.79%-1.65K | -10.45%-595.62K | 90.28%-71.66K | -20.31%-2.58M | -16.45%-530.13K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -2.14K | 0 | 1.02K | -100.61%-1.08K | -99.98%32 | 0 | -1.11K | 0 | 1,338.00%177.69K | 5,112.66%180.91K |
Net PPE purchase and sale | ---2.14K | --0 | ---- | 66.49%-1.08K | --32 | --0 | ---1.11K | ---- | 77.59%-3.22K | --0 |
Net business purchase and sale | --0 | --0 | --1.02K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --180.91K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---2.14K | --0 | --1.02K | -100.61%-1.08K | -99.98%32 | --0 | ---1.11K | --0 | 1,338.00%177.69K | 5,112.66%180.91K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 56.20%-17.49K | -76.22%99.65K | -80.50%28.08K | -71.17%598.14K | -72.90%74.97K | -121.30%-39.92K | -55.80%419.11K | -78.26%143.98K | 9.69%2.07M | 2,184.07%276.66K |
Net issuance payments of debt | 60.64%-17.49K | 95.94%-13.42K | -103.77%-5.42K | -208.36%-213.23K | -92.57%17.58K | -233.08%-44.42K | -2,388.60%-330.36K | 1,184.52%143.98K | 470.55%196.77K | 1,882.75%236.66K |
Net common stock issuance | --0 | -84.43%117.5K | --33.5K | -55.70%816.68K | --57.4K | -97.20%4.5K | -23.49%754.79K | --0 | -12.22%1.84M | --0 |
Cash dividends paid | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 2,122.22%100K | --40K |
Interest paid (cash flow from financing activities) | --0 | ---4.43K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | 91.88%-5.32K | --0 | ---- | 88.21%-5.32K | ---- | 59.09%-65.5K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 56.20%-17.49K | -76.22%99.65K | -80.50%28.08K | -71.17%598.14K | -72.90%74.97K | -121.30%-39.92K | -55.80%419.11K | -78.26%143.98K | 9.69%2.07M | 2,184.07%276.66K |
Net cash flow | ||||||||||
Beginning cash position | 663.68%164.8K | -60.75%78.19K | 14.11%144.78K | -71.81%126.88K | -110.02%-19.99K | -97.24%21.58K | -46.65%199.2K | -71.81%126.88K | -36.95%450.17K | -78.37%199.45K |
Current changes in cash | 183.77%34.82K | 148.76%86.61K | -192.08%-66.59K | 105.54%17.9K | 327.06%164.77K | 92.87%-41.57K | -143.43%-177.62K | 194.20%72.32K | -22.55%-323.29K | 84.63%-72.57K |
End cash Position | 1,098.54%199.62K | 663.68%164.8K | -60.75%78.19K | 14.11%144.78K | 14.11%144.78K | -110.02%-19.99K | -97.24%21.58K | -46.65%199.2K | -71.81%126.88K | -71.81%126.88K |
Free cash from | 3,275.96%52.31K | 97.81%-13.05K | -33.52%-95.68K | 77.50%-580.24K | 116.94%89.8K | 99.79%-1.65K | -10.65%-596.73K | 90.30%-71.66K | -19.66%-2.58M | -15.54%-530.13K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data